These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Identification and functional characterization of the putative polysaccharide biosynthesis protein (CapD) of Enterococcus faecium U0317. Ali L; Spiess M; Wobser D; Rodriguez M; Blum HE; Sakιnç T Infect Genet Evol; 2016 Jan; 37():215-24. PubMed ID: 26611826 [TBL] [Abstract][Full Text] [Related]
12. The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis. Hendrickx AP; van Schaik W; Willems RJ Future Microbiol; 2013 Aug; 8(8):993-1010. PubMed ID: 23902146 [TBL] [Abstract][Full Text] [Related]
13. Enterococcal surface protein contributes to persistence in the host but is not a target of opsonic and protective antibodies in Enterococcus faecium infection. Sava IG; Heikens E; Kropec A; Theilacker C; Willems R; Huebner J J Med Microbiol; 2010 Sep; 59(Pt 9):1001-1004. PubMed ID: 20522627 [TBL] [Abstract][Full Text] [Related]
14. Immunochemical characterization of polysaccharide antigens from six clinical strains of Enterococci. Hsu CT; Ganong AL; Reinap B; Mourelatos Z; Huebner J; Wang JY BMC Microbiol; 2006 Jul; 6():62. PubMed ID: 16836754 [TBL] [Abstract][Full Text] [Related]
15. Identification of SagA as a novel vaccine target for the prevention of Enterococcus faecium infections. Kropec A; Sava IG; Vonend C; Sakinc T; Grohmann E; Huebner J Microbiology (Reading); 2011 Dec; 157(Pt 12):3429-3434. PubMed ID: 21903755 [TBL] [Abstract][Full Text] [Related]
16. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli. Welch WD; Martin WJ; Stevens P; Young LS Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778 [TBL] [Abstract][Full Text] [Related]
17. [Enterococcal infections. Clinical findings and treatment considering antibiotic resistance in Denmark]. Olesen HV; Møller JK Ugeskr Laeger; 2002 Apr; 164(18):2386-90. PubMed ID: 12024841 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Huebner J; Quaas A; Krueger WA; Goldmann DA; Pier GB Infect Immun; 2000 Aug; 68(8):4631-6. PubMed ID: 10899866 [TBL] [Abstract][Full Text] [Related]
19. Chemical structure of wall teichoic acid isolated from Enterococcus faecium strain U0317. Bychowska A; Theilacker C; Czerwicka M; Marszewska K; Huebner J; Holst O; Stepnowski P; Kaczyński Z Carbohydr Res; 2011 Dec; 346(17):2816-9. PubMed ID: 22024569 [TBL] [Abstract][Full Text] [Related]
20. Investigation of cross-opsonic effect leads to the discovery of PPIase-domain containing protein vaccine candidate to prevent infections by Gram-positive ESKAPE pathogens. Sadones O; Kramarska E; Laverde D; Berisio R; Huebner J; Romero-Saavedra F BMC Microbiol; 2024 Jul; 24(1):280. PubMed ID: 39068414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]